A Study to Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN)
Clinical trial NCT02550652 · COMPLETED
Trial details
- NCT number
- NCT02550652
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-13
- Primary completion
- 2019-01-15
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.